CFG
ADNT icon

Cambridge Financial Group’s Adient ADNT Stock Holding History

Cambridge Financial Group’s Portfolio ADNT Stock Details ADNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-10,759
Closed -$630K – 32
2016
Q4 		$630K Buy
+10,759
New +$568K 0.37% 32

Other funds holding ADNT

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
LCM
Lakewood Capital Management New York $1.58B AUM 0.92% 1-Year Est. Return
KCM
Kingstown Capital Management New York $30.4M AUM 3.71% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
EM
Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return
BHG
Blue Harbour Group Greenwich, Connecticut $353M AUM 8.9% 1-Year Est. Return

Cambridge Financial Group's ADNT Position: Q1 2017 in Review

Cambridge Financial Group sold out of Adient (ADNT) in Q1 2017, closing a stake of 10,759 shares — an estimated $630K sold.

Cambridge Financial Group first reported a position in ADNT in Q4 2016 and held it in 1 quarter. The position peaked at $630K in Q4 2016. 452 funds tracked by Wall St. Rank hold ADNT as of Q1 2017.

  • Cambridge Financial Group reported no remaining Adient position as of Q1 2017 after selling out during the quarter.
  • Cambridge Financial Group sold 10,759 Adient shares in Q1 2017, an estimated $630K.
  • Cambridge Financial Group first reported a position in Adient in Q4 2016 and held it in 1 quarter.
  • Cambridge Financial Group's Adient position peaked at $630K in Q4 2016.
  • 452 funds tracked by Wall St. Rank held Adient as of Q1 2017.

Based on Cambridge Financial Group's 13F filing for Q1 2017, filed 15 May 2017.